Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q4 2025 Earnings

Nov 4Confirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-0.6

-0.43

-0.27

-0.1

Details

Expected EPS

-0.126943

Actual EPS

-0.12

Surprise EPS

0.01

Surprise Percent

+5.47%

Description

⁨Corvus Pharmaceuticals⁩ (⁦CRVS⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.